Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19John C. Marshall, Jonathan A C Sterne, Srinivas Murthy et al.|JAMA|2020Cited by 2.4k
A minimal common outcome measure set for COVID-19 clinical researchJohn C. Marshall, Halima Salisu-Kabara, Nina Gobat et al.|The Lancet Infectious Diseases|2020Cited by 1.8k
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19Derek C. Angus, Balasubramanian Venkatesh, Lennie Derde et al.|JAMA|2020Cited by 884
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C. Angus, Steven Webb, Scott Berry et al.|Annals of the American Thoracic Society|2020Cited by 449
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary reportChristopher W. Seymour, Anthony Gordon, Paul Mouncey et al.|medRxiv|2021Cited by 137